16 (Cassipa Sublingual Film buprenorphine hydrochloride 16 mg / naloxone hydrochloride 4 mg)
Generic Name: buprenorphine/naloxone
Film with imprint 16 is Orange, Rectangle and has been identified as Cassipa Sublingual Film buprenorphine hydrochloride 16 mg / naloxone hydrochloride 4 mg. It is supplied by Teva Pharmaceuticals USA, Inc..
Cassipa is used in the treatment of opiate dependence and belongs to the drug class narcotic analgesic combinations. Risk cannot be ruled out during pregnancy. Cassipa buprenorphine hydrochloride 16 mg / naloxone hydrochloride 4 mg is classified as a Schedule 3 controlled substance under the Controlled Substance Act (CSA).
Images for 16
- Generic Name
- buprenorphine hydrochloride 16 mg / naloxone hydrochloride 4 mg
- Prescription only
- Drug Class
- Narcotic analgesic combinations
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- 3 - Moderate abuse potential
- Labeler / Supplier
- Teva Pharmaceuticals USA, Inc.
- National Drug Code (NDC)
Related Images for "16"
More about Cassipa (buprenorphine / naloxone)
- Side Effects
- During Pregnancy
- Dosage Information
- Imprints, Shape & Color Data
- Drug Interactions
- Drug class: narcotic analgesic combinations
- FDA Alerts (1)
- FDA Approval History
Related treatment guides
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.